Workplace-Irritant Assessment in 316 Suspected Hand-Dermatitis Patients

November 11, 2026

Doctor’s Notes · Life in Motion · Evidence Review

Editorial disclosure: The featured image is an AI-created illustration of a fictional work or daily-life scene. It is not a patient, diagnosis, before-and-after image or Dr. Arsy #003 treatment result.

Reader question: What did structured workplace-exposure assessment add for 316 patients with suspected occupational hand dermatitis?

Study snapshot

Study element	Reported detail
Population	316 patients referred with suspected occupational hand dermatitis to Copenhagen University Hospital Gentofte.
Design	Prospective clinical program combining examination, workplace-exposure assessment and extensive patch and prick testing.
Comparator	Diagnoses and identified exposures were compared within the referred cohort; there was no unexposed external control group.
Timepoint	Referrals from January 2010 through August 2011.
Key result	Occupational contact dermatitis was diagnosed in 228 patients and occupational irritant contact dermatitis in 118. Among those 118, identified irritants included wet work in 64, gloves in 45, mechanical trauma in 19 and oils in 15. Specific irritant chemicals were found in nine patients, eight through safety sheets or ingredient labels.
Funding/conflict context	PubMed indexes non-U.S. governmental research support; the abstract does not report conflicts. The program did not evaluate skin-care products.

What was actually measured?

Occupational contact dermatitis was diagnosed in 228 patients and occupational irritant contact dermatitis in 118. Among those 118, identified irritants included wet work in 64, gloves in 45, mechanical trauma in 19 and oils in 15. Specific irritant chemicals were found in nine patients, eight through safety sheets or ingredient labels.

The useful contribution is the structured comparison between clinical diagnosis and documented workplace exposure, including concurrent allergen review—not a claim that a safety sheet alone can diagnose dermatitis.

The denominator defines the scope. A patch-test clinic, selected case series, compensation registry, online questionnaire, workplace cohort and general-population survey answer different questions. A percentage from one cannot be silently transferred to the others.

What the result does not prove

A referred specialty-clinic cohort is selected, exposures were assessed rather than experimentally assigned, and the authors found that safety sheets had a limited role in identifying irritants.

Association, timing and biological plausibility can strengthen an occupational interpretation, but observational evidence cannot automatically establish individual causation. Referral patterns, reporting practices, task mix, protective equipment, nonwork exposures and access to care may all change an estimate.

A PubMed record is a bibliographic source. PubMed indexing is not NIH endorsement of the authors' conclusions, this interpretation or any product.

Exposure detail matters more than the job label

Workers with the same title can handle different materials for different durations. Useful documentation identifies the exact product or process, the route of contact, glove or PPE material, wetness, friction, heat, dust, splash potential, frequency and how symptoms change away from the task.

A symptom survey can identify a pattern, a clinical examination can refine the differential diagnosis, and patch testing can identify delayed sensitization. None of those steps alone proves that a workplace material caused an individual condition. Clinical relevance still requires a credible exposure and time course.

Questions worth recording

Which task, product, glove, tool, metal, resin, cleanser, food, plant, dust or surface came before symptoms?
Where did the change begin, and did it improve on days away or after a process or PPE change?
How often were hands wet, washed, disinfected, occluded, rubbed, heated or exposed to cold?
Were labels, ingredient information and safety-data sheets reviewed with occupational health?
Did the problem affect dexterity, sleep, pace, attendance, work quality or safety?

Prevention comes before cosmetic care

Substitution, closed systems, local exhaust, splash control, safer cleaning methods, training and correctly selected protective equipment address exposure at its source. Gloves are not automatically protective: material, fit, breakthrough time, sweating, reuse and rubber accelerators all matter.

Do not deliberately place workplace products on skin to test a theory. Persistent, recurrent or spreading symptoms, drainage, fever, breathing symptoms, severe pain, rapidly worsening redness or major loss of function warrant professional evaluation.

Primary research and guidance

Where Dr. Arsy #003 fits

Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003. Its findings do not show that #003 treats, cures or prevents eczema, relieves pain or itch, neutralizes workplace chemicals, is appropriate for every person, or provides pediatric or 24-hour efficacy.

Continue the evidence series

Evidence note: This educational article separates reported findings from interpretation. It is not a diagnosis, treatment recommendation or workplace-safety determination.

← Back to Doctor's Notes